Skip to content
Calculator
Evidence review

Collagen Peptides: What the Randomised Trials Show for Skin, Joints and Bone

Last updated: October 27, 2026 · 10 min read · By the Grey Peptides Editorial Board

White powder spilled from a scoop on a bright blue background
Photo by Towfiqu barbhuiya on Pexels
Grey Peptides
Grey Peptides Editorial Board
Every status on this page carries the date it was checked. How we work
Key takeaways
  • Three meta-analyses of oral collagen, covering 19, 26 and 14 randomised trials, all find improvements in skin hydration and elasticity against placebo 4 2 5.
  • Those are the two outcomes all three agree on; only the 19-trial analysis reported a benefit for wrinkles. The outcomes are instrument readings of the skin 4 2 5.
  • The doses studied are specific: 2.5 to 10 g a day for skin over 8 to 24 weeks, 5 g for knee discomfort and bone density, 15 g alongside resistance training for muscle 7 9 10 12.
  • Read who ran the studies: four of the trials cited here list co-authors at a private collagen research company, and a published letter in the same journal took issue with the heterogeneity of the trials pooled in the 19-trial skin meta-analysis 6.
  • Collagen peptides are a dietary supplement, not a drug. In the United States a seller may claim an effect on structure or function, must hold substantiation, and must print that FDA has not evaluated the claim 1.

First, this is a different category from the rest of this site

Many compounds in our encyclopedia are injected, unapproved, and supported by a handful of human studies or none. Collagen peptides are taken by mouth, sold as a dietary supplement 1, and tested in dozens of randomised placebo-controlled trials 2. A tub of collagen powder and a vial of BPC-157 have almost nothing in common beyond the word peptide.

"Hydrolysed" is the other word worth decoding: hydrolysed collagen is collagen broken into short fragments, and some of those fragments, such as the tripeptide glycine-proline-hydroxyproline, are measurable in blood after a dose 3. "Collagen peptides", "hydrolysed collagen" and "collagen hydrolysate" are used for the same kind of product; "marine", "bovine" and "porcine" describe the animal it came from.

The idea that eaten collagen becomes collagen in the skin is not what the trials test. They measure skin, joint and bone outcomes, and an effect on skin hydration does not demonstrate that any eaten collagen became skin.

Skin: three meta-analyses, two outcomes that hold up

This is where the evidence is strongest. Three systematic reviews with meta-analyses have pooled the randomised trials, and they broadly agree.

The largest by trial count pooled 26 randomised controlled trials in 1,721 people and found significant improvements in skin hydration and in elasticity against placebo. Its authors also identified several biases in the trials they included and called for larger studies.2 An earlier analysis of 19 double-blind randomised trials in 1,125 participants, 95% of them women aged 20 to 70, found favourable results for hydration, elasticity and wrinkles, and concluded that 90 days of intake reduces signs of skin ageing.4 A third, of 14 trials in 967 participants, again found moisture and elasticity improved over a 12-week regimen.5

Two cautions belong beside those results, and they come from the literature itself rather than from us. First, a letter published in the same journal as the 19-trial analysis commented on it, under the title "Concerning the heterogeneity of the studies included in meta-analyses".6 That is a published objection, and anyone citing the headline figure should know it exists. The 26-trial analysis, published two years later, identified several biases in its own included trials.2

Second, the outcomes are instrument readings. Hydration is measured by corneometry, elasticity by cutometry — devices pressed against the forearm or face. An earlier dermatology review of 11 randomised trials in 805 patients, eight of which used collagen hydrolysate at 2.5 to 10 g a day for 8 to 24 weeks for pressure ulcers, dry skin, skin ageing and cellulite, noted that regulation on quality, absorption and efficacy is lacking.7 An instrument reading is not the same as a change visible in the mirror; it is a smaller claim.

Joints: a large short-term effect, in a field full of them

The most useful single paper here is not about collagen at all. A systematic review and meta-analysis of 20 dietary supplements across 69 randomised trials in hand, hip and knee osteoarthritis put collagen hydrolysate among seven supplements showing large effect sizes, above 0.80, and clinically important pain reduction in the short term.8 There are three qualifications in the same paper: those effects were short-term only, no supplement showed clinically important pain reduction at long term, and the quality of evidence across the field ranged from very low to high.

A trial in people without diagnosed arthritis, co-authored by a private collagen research company, tested 5 g a day of bioactive collagen peptides for 12 weeks in 139 athletic adults with activity-related knee pain, and reported a statistically significant improvement in pain intensity against placebo.9 That is a real randomised result in a defined population: young active people with knee discomfort, not patients with diagnosed osteoarthritis, and not a structural change in the joint.

What none of this establishes is that collagen rebuilds cartilage. Pain and function are what the trials measured. In the 20-supplement review, the only structural improvement found was chondroitin's, statistically significant but not clinically important.8

Bone and muscle: smaller literatures, more specific claims

For bone, the main trial, co-authored by the same company, randomised 131 postmenopausal women with age-related reduction in bone mineral density to 5 g a day of specific collagen peptides or placebo for 12 months. Bone mineral density increased in the collagen group at the spine and femoral neck, and the bone formation marker P1NP rose in that group while the resorption marker CTX-1 rose in the control group; 102 of the 131 finished.10 An open-label follow-up of 31 of those women after four years reported continued increases.11 Note what the follow-up is: open-label, uncontrolled, and a quarter of the original sample. It is supportive, not confirmatory.

For muscle, the design matters more than the supplement. Fifty-three older men with sarcopenia did a 12-week guided resistance training programme and took either 15 g a day of collagen peptides or a silica placebo; the collagen group gained more fat-free mass and strength.12 Everyone trained. The question the trial answers is whether collagen adds to resistance training, not whether it does anything without it.

A 2025 randomised study tested the mechanism directly, using infused labelled phenylalanine in 45 young adults after resistance exercise. Neither 30 g of hydrolysed collagen nor the same amino acids given free raised myofibrillar or muscle connective protein synthesis above a placebo drink, at rest or after exercise, although both raised blood amino acids.13 On that measure, collagen was not special.

Who paid for these trials

This is not a reason to dismiss the evidence. It is a reason to read it carefully.

Four of the trials cited on this page, the knee, bone, bone follow-up and sarcopenia trials, list co-authors at the Collagen Research Institute, a private company in Kiel, and the follow-up's first two authors are affiliated with it.9 10 11 12 The phrase "specific collagen peptides" or "bioactive collagen peptides" in those titles names particular preparations. Commercial involvement does not make a result false. It does mean that the product tested is a specific preparation, not collagen in general, and that a reader should look for replication by independent groups; the 26-trial meta-analysis itself identified several biases in the trials it pooled.2

The practical consequence for a reader is that the evidence supports a narrower claim than it appears to. "Collagen peptides improved skin elasticity" is supported. "This tub of collagen will improve your skin elasticity" requires that the tub contains the same preparation at the same dose, which is rarely checkable from a label.

The doses actually studied

Trials use specific amounts, and they are not the amounts on every label.

  • Skin: 2.5 to 10 g a day, for 8 to 24 weeks, across eight trials in the dermatology review.7 One frequently cited trial compared 2.5 g with 5 g in 69 women aged 35 to 55 over 8 weeks.14
  • Knee discomfort: 5 g a day for 12 weeks in athletic adults.9
  • Bone mineral density: 5 g a day for 12 months in postmenopausal women.10
  • Muscle with resistance training: 15 g a day for 12 weeks in older men with sarcopenia.12

Two things follow. The dose studied for one outcome is not the dose studied for another, and the muscle dose, 15 g, is above the whole skin range. And every one of these results came with a fixed duration: the shortest skin trials run eight weeks, the bone trial a year. Nothing here supports judging a product after a fortnight.

What a seller is allowed to say

In the United States collagen peptides are a dietary supplement, which sets the rules for the marketing around them. A seller may make a structure/function claim — a statement about how an ingredient affects the structure or function of the body. FDA does not pre-approve those claims. The manufacturer must hold support showing the claim is "truthful and not misleading", must submit a notification with the text of the claim to FDA no later than 30 days after marketing, and must print a disclaimer stating that FDA has not evaluated the claim and that the product is not intended to "diagnose, treat, cure or prevent any disease" (FDA's page, content current as of March 28, 2024).1

That is why labels say "supports skin elasticity" rather than "treats wrinkles": the disclaimer itself says the product is not intended to treat any disease. Reading that distinction on a label tells you which legal category you are in, and therefore what evidence stands behind the sentence.

We checked the European position directly and could not read it: EFSA's site refused automated access on October 1, 2026. Rather than repeat a widely circulated claim about what EFSA has authorised, we state only what we verified ourselves, which is the US position above.

What a fair summary looks like

Collagen peptides have more randomised human evidence than most of the unapproved peptides on this site. Three meta-analyses agree on hydration and elasticity, and the bone and knee trials are randomised results. They are also small, measured by instruments, often co-authored by a commercial collagen research company, and the pooling of the skin trials has been questioned in print.

So the fair summary is narrow and dull: at 2.5 to 10 g a day for at least two to three months, hydrolysed collagen produces measurable improvements in skin hydration and elasticity against placebo, with weaker and less consistent evidence for wrinkles, short-term benefit for joint pain in a field where many supplements show short-term benefit, and one year-long bone trial, co-authored by a commercial collagen research company, that has not been replicated by an independent group in the literature cited here.

If what brought you here was a search for peptides, our collagen peptides entry keeps the evidence and status in one place, and the rest of the encyclopedia covers the injectable compounds that share the word and nothing else.

Frequently asked questions

Do collagen peptides actually work?

For two specific outcomes, the randomised evidence says yes: skin hydration and skin elasticity improved against placebo across three meta-analyses covering 19, 26 and 14 trials. Those are instrument measurements rather than visible change, and several of the trials have commercial co-authors.

How much collagen should I take?

The trials used 2.5 to 10 g a day for skin over 8 to 24 weeks, 5 g for knee discomfort and for bone density, and 15 g alongside resistance training for muscle. The dose that worked for one outcome is not the dose that worked for another, and nothing was tested for less than eight weeks.

Are collagen peptides the same as the peptides sold for healing or weight loss?

No. Collagen peptides are eaten, sold as a dietary supplement and tested in dozens of randomised trials. Compounds like BPC-157 or retatrutide are injected, unapproved as research chemicals or still in trials, and supported by far less human evidence. They share a word, not a category.

Does it matter whether collagen is marine, bovine or porcine?

The source describes the animal, not the effect. One meta-analysis found that effects on hydration varied by source and duration, while effects on elasticity did not differ significantly between sources.

Does eating collagen become collagen in my skin?

The trials do not test it. Hydrolysed collagen is broken into short fragments, some of which appear in blood, and an improvement in a skin measurement does not show that eaten collagen became skin.

Can a company say collagen treats wrinkles?

Not in the United States. As a dietary supplement it may carry a structure/function claim such as 'supports skin elasticity', must hold substantiation, must notify FDA no later than 30 days after marketing, and must print that FDA has not evaluated the claim and that the product is not intended to diagnose, treat, cure or prevent any disease.

Sources

  1. US Food and Drug Administration. Structure/Function Claims (content current as of March 28, 2024). Read October 1, re-read October 27, 2026. FDA
  2. Pu, S.-Y. et al. (2023). Effects of Oral Collagen for Skin Anti-Aging: A Systematic Review and Meta-Analysis. Nutrients, 15(9), 2080. PMID: 37432180
  3. Latini, L. et al. (2026). Clinical evidence for low-molecular-weight collagen peptides in tendon and ligament tears: a systematic review with narrative synthesis. Frontiers in Medicine, 13, 1891011. PMID: 42666580
  4. de Miranda, R. B. et al. (2021). Effects of hydrolyzed collagen supplementation on skin aging: a systematic review and meta-analysis. International Journal of Dermatology, 60(12), 1449-1461. PMID: 33742704
  5. Dewi, D. A. R. et al. (2023). Exploring the Impact of Hydrolyzed Collagen Oral Supplementation on Skin Rejuvenation: A Systematic Review and Meta-Analysis. Cureus, 15(12), e50231. PMID: 38192916
  6. Peres, G. et al. (2022). Concerning the heterogeneity of the studies included in meta-analyses. Comment on: 'Effects of hydrolyzed collagen supplementation on skin aging'. International Journal of Dermatology, 61(3), e99-e101. PMID: 34196407
  7. Choi, F. D. et al. (2019). Oral Collagen Supplementation: A Systematic Review of Dermatological Applications. Journal of Drugs in Dermatology, 18(1), 9-16. PMID: 30681787
  8. Liu, X. et al. (2018). Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis. British Journal of Sports Medicine, 52(3), 167-175. PMID: 29018060
  9. Zdzieblik, D. et al. (2017). Improvement of activity-related knee joint discomfort following supplementation of specific collagen peptides. Applied Physiology, Nutrition, and Metabolism, 42(6), 588-595. PMID: 28177710
  10. König, D. et al. (2018). Specific Collagen Peptides Improve Bone Mineral Density and Bone Markers in Postmenopausal Women - A Randomized Controlled Study. Nutrients, 10(1), 97. PMID: 29337906
  11. Zdzieblik, D. et al. (2021). Specific Bioactive Collagen Peptides in Osteopenia and Osteoporosis: Long-Term Observation in Postmenopausal Women. Journal of Bone Metabolism, 28(3), 207-213. PMID: 34520654
  12. Zdzieblik, D. et al. (2015). Collagen peptide supplementation in combination with resistance training improves body composition and increases muscle strength in elderly sarcopenic men. British Journal of Nutrition, 114(8), 1237-1245. PMID: 26353786
  13. Aussieker, T. et al. (2025). The Effects of Ingesting a Single Bolus of Hydrolyzed Collagen versus Free Amino Acids on Muscle Connective Protein Synthesis Rates. Medicine and Science in Sports and Exercise, 57(11), 2394-2408. PMID: 40523226
  14. Proksch, E. et al. (2014). Oral supplementation of specific collagen peptides has beneficial effects on human skin physiology: a double-blind, placebo-controlled study. Skin Pharmacology and Physiology, 27(1), 47-55. PMID: 23949208

This article is for education. It is not medical advice and it is not a recommendation to take or avoid any supplement. Collagen peptides are a food ingredient sold as a dietary supplement; if you are being treated for osteoporosis, arthritis or any other condition, the treatment your clinician prescribed is the one with evidence behind it for that condition.

All articles

New guides and rule changes, by email

One short email when a peptide's legal status moves — an FDA or PCAC decision, a WADA list change, an enforcement action — plus new guides and tools. At most one a week, and none when nothing changes. The newsletter has not started sending yet: your first email will be its first issue.

We keep your email address and the page you signed up from, nothing else. How it works · Privacy · RSS instead